This was a randomized, head-to-head comparison that enrolled 751 individuals and found those who took tirzepatide lost 20% of their body weight, about 50 pounds on average, while those on semaglutide lost 14% of their body weight, or about 33 pounds on average
The Healthcare Insurance Reciprocal of Canada (HIROC) provides support for the bulletin and is a member owned expert provider of professional and general liability coverage and risk management support
This guide covers everything Hashimoto's patients need to understand about GLP-1 therapy , from the research on safety and thyroid function to practical monitoring schedules, supplement considerations , medication timing, and the specific scenarios where these medications could genuinely help versus situations where caution is warranted
Uninsured patients can work with a telehealth provider to complete these checks before committing to a monthly subscription
The same has not been clearly shown for cholesterol